Incidence and timing of common adverse events in Lenvatinib-treated patients from the SELECT trial and their association with survival outcomes
Crossref DOI link: https://doi.org/10.1007/s12020-017-1233-5
Published Online: 2017-02-03
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Haddad, Robert I.
Schlumberger, Martin
Wirth, Lori J.
Sherman, Eric J.
Shah, Manisha H.
Robinson, Bruce
Dutcus, Corina E.
Teng, Angela
Gianoukakis, Andrew G.
Sherman, Steven I.
License valid from 2017-02-03